Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11298378-B2 United States of America 12 Apr 2022
CHIMERIC ANTIGEN RECEPTORS TARGETING THE TUMOR MICROENVIRONMENT Application EP-3752170-A4 European Patent Office 30 Mar 2022
CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19 Application EP-3793578-A4 European Patent Office 23 Mar 2022
Methods and compositions for treating cancer Grant US-11254912-B2 United States of America 22 Feb 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11242376-B2 United States of America 08 Feb 2022
METHODS AND COMPOSITIONS RELATING TO ENGINEERED REGULATORY T CELLS Application EP-3697820-A4 European Patent Office 05 Jan 2022
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof Grant US-11207349-B2 United States of America 28 Dec 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11207351-B2 United States of America 28 Dec 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11202802-B2 United States of America 21 Dec 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11191783-B2 United States of America 07 Dec 2021
IL-15-based molecules and methods of use thereof Grant US-11173191-B2 United States of America 16 Nov 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11166985-B2 United States of America 09 Nov 2021
CELL CLASSIFIER CIRCUITS AND METHODS OF USE THEREOF Application WO-2021209813-A2 World Intellectual Property Organisation (WIPO) 21 Oct 2021
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen… Grant US-11149076-B2 United States of America 19 Oct 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11135247-B2 United States of America 05 Oct 2021
COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND APPLICATIONS THEREOF Application WO-2021188681-A1 World Intellectual Property Organisation (WIPO) 23 Sep 2021
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof Application US-20210290673-A1 United States of America 23 Sep 2021
Multimeric IL-15 soluble fusion molecules and methods of making and using same Grant US-11104716-B2 United States of America 31 Aug 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11085021-B2 United States of America 10 Aug 2021
Multimeric IL-15 soluble fusion molecules and methods of making and using same Grant US-11046747-B2 United States of America 29 Jun 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11028142-B2 United States of America 08 Jun 2021
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding… Grant US-11026976-B2 United States of America 08 Jun 2021
ULTRAMODULAR IGG3-BASED SPACER DOMAIN AND MULTI-FUNCTION SITE FOR IMPLEMENTATION IN… Application WO-2020254591-A1 World Intellectual Property Organisation (WIPO) 24 Dec 2020
LOCKR-MEDIATED RECRUITMENT OF CAR T CELLS Application WO-2020232447-A1 World Intellectual Property Organisation (WIPO) 19 Nov 2020
Natural killer cells modified to express membrane-bound interleukin 15 and uses thereof Grant US-10774311-B2 United States of America 15 Sep 2020
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding… Grant US-10525083-B2 United States of America 07 Jan 2020
Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy Application US-10442867-B2 United States of America 15 Oct 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10442849-B2 United States of America 15 Oct 2019
ADHESION RECEPTOR CONSTRUCTS AND USES THEREOF IN NATURAL KILLER CELL IMMUNOTHERAPY Application WO-2019155286-A3 World Intellectual Property Organisation (WIPO) 26 Sep 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358474-B2 United States of America 23 Jul 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358473-B2 United States of America 23 Jul 2019
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen… Grant US-10253086-B2 United States of America 09 Apr 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10208285-B2 United States of America 19 Feb 2019
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD19/CD20 IMMUNOTHERAPY Application WO-2019028051-A1 World Intellectual Property Organisation (WIPO) 07 Feb 2019
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN… Application WO-2016164731-A3 World Intellectual Property Organisation (WIPO) 10 Nov 2016